https://ir.icecure-medical.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_54f40390b69697dace3343a57e47c1a7/icecuremedical/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.icecure-medical.com/news-events/press-releases/detail/231/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-guidelines-citing-icecures-fda-clearance-of-prosense Wed, 29 Jul 26 08:25:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/231/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-guidelines-citing-icecures-fda-clearance-of-prosense https://ir.icecure-medical.com/news-events/press-releases/detail/230/icecure-medical-kicks-off-its-post-marketing-choice-study-for-the-low-risk-breast-cancer-treatment-at-first-u-s-clinical-site Mon, 27 Jul 26 08:32:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/230/icecure-medical-kicks-off-its-post-marketing-choice-study-for-the-low-risk-breast-cancer-treatment-at-first-u-s-clinical-site https://ir.icecure-medical.com/news-events/press-releases/detail/229/icecure-expands-u-s-commercial-team-to-meet-surging-demand-for-prosense-cryoablation Tue, 14 Jul 26 08:32:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/229/icecure-expands-u-s-commercial-team-to-meet-surging-demand-for-prosense-cryoablation https://ir.icecure-medical.com/news-events/press-releases/detail/228/icecure-highlights-expanding-commercial-adoption-of-prosense-cryoablation-in-brazil-following-fda-clearance-for-breast-cancer Mon, 06 Jul 26 08:11:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/228/icecure-highlights-expanding-commercial-adoption-of-prosense-cryoablation-in-brazil-following-fda-clearance-for-breast-cancer https://ir.icecure-medical.com/news-events/press-releases/detail/227/icecure-regains-compliance-with-nasdaq-minimum-bid-price-requirement Thu, 25 Jun 26 08:12:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/227/icecure-regains-compliance-with-nasdaq-minimum-bid-price-requirement https://ir.icecure-medical.com/news-events/press-releases/detail/226/icecure-highlights-new-peer-reviewed-journal-article-in-leading-surgery-journal-demonstrating-cryoablations-advantages-over-radiofrequency-ablation-for-early-stage-breast-cancer Tue, 23 Jun 26 08:10:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/226/icecure-highlights-new-peer-reviewed-journal-article-in-leading-surgery-journal-demonstrating-cryoablations-advantages-over-radiofrequency-ablation-for-early-stage-breast-cancer https://ir.icecure-medical.com/news-events/press-releases/detail/225/icecure-announces-pricing-of-5-5-million-private-placement-priced-at-a-premium-to-the-market-price-with-a-single-healthcare-focused-institutional-investor Wed, 17 Jun 26 13:14:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/225/icecure-announces-pricing-of-5-5-million-private-placement-priced-at-a-premium-to-the-market-price-with-a-single-healthcare-focused-institutional-investor https://ir.icecure-medical.com/news-events/press-releases/detail/224/icecure-reports-70-growth-in-active-u-s-commercial-install-base-for-breast-cancer-cryoablation-following-fda-clearance Wed, 17 Jun 26 08:25:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/224/icecure-reports-70-growth-in-active-u-s-commercial-install-base-for-breast-cancer-cryoablation-following-fda-clearance https://ir.icecure-medical.com/news-events/press-releases/detail/223/icecure-medical-announces-1-for-30-reverse-share-split-to-support-nasdaq-compliance Tue, 02 Jun 26 08:30:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/223/icecure-medical-announces-1-for-30-reverse-share-split-to-support-nasdaq-compliance https://ir.icecure-medical.com/news-events/press-releases/detail/222/icecures-prosense-reports-nearly-90-recurrence-free-rate-for-cryoablation-of-kidney-cancer-data-presented-at-ecio-2026-and-first-ever-breast-cryoablation-master-class-overbooked Tue, 19 May 26 08:30:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/222/icecures-prosense-reports-nearly-90-recurrence-free-rate-for-cryoablation-of-kidney-cancer-data-presented-at-ecio-2026-and-first-ever-breast-cryoablation-master-class-overbooked